Biochemical markers in the diagnosis of myocardial infarction

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10283139" target="_blank" >RIV/00216208:11110/14:10283139 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/14:10283139
Result on the web
<a href="http://dx.doi.org/10.1016/j.crvasa.2014.06.007" target="_blank" >http://dx.doi.org/10.1016/j.crvasa.2014.06.007</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.crvasa.2014.06.007" target="_blank" >10.1016/j.crvasa.2014.06.007</a>

Result language
angličtina
Original language name
Biochemical markers in the diagnosis of myocardial infarction
Original language description
The diagnosis of myocardial necrosis due to acute myocardial infarction (AMI) and other causes has long been based on the plasma levels of cardiac troponins. Other markers of myocardial injury such as myoglobin, heart-type fatty acid binding protein, glycogen phosphorylase isoenzyme BB, or the early and sensitive total stress marker copeptin remain to be just attractive options used primarily to early rule out AMI and in risk stratification. Recent years have seen the introduction of a routine practiceof the high-sensitivity cardiac troponin assays capable of detecting diagnostic elevations in plasma troponin levels as early as the first hours of myocardial injury. However, this assay tends to identify very often low plasma troponin levels in primarily noncardiac conditions and also in healthy or apparently healthy individuals. Hence, this novel technology warrants further study.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)